Britain's drug regulator authorized the Alzheimer's drug Leqembi on Thursday, saying it's the first medicine to show some impact in slowing the...
Vous n'êtes pas connecté
Inovio (INO) soars 19% as its lead candidate, INO-3107, receives the innovative medicine tag under the U.K.'s Innovative Licensing and Access Pathway to treat recurrent respiratory papillomatosis.
Britain's drug regulator authorized the Alzheimer's drug Leqembi on Thursday, saying it's the first medicine to show some impact in slowing the...
When countries are unable to repay debts, domestic financing for health, education or social protection gets slashed which disproportionately...
Decision by Nice to rule out drug being available on NHS comes despite medicines licensing body giving green light
Bristol Myers' (BMY) application seeking approval for the Opdivo/Yervoy combo to treat unresectable hepatocellular carcinoma gets accepted for FDA...
The vice-presidential candidate steps out of his flannels and into the spotlight.
The FDA bestows a Breakthrough Therapy Designation to GSK's B7-H3-targeted antibody-drug conjugate, GSK5764227, for relapsed/refractory...
Multiple sclerosis has a potential treatment under clinical trials - An antiallergy drug and green mamba snake toxin lead the way to discovery of...
Liver disease is a common condition affecting millions of adults in the United States. One serious form of this disease is nonalcoholic fatty liver...
AbbVie's (ABBV) Tepkinly gets conditional approval in the EU to treat third-line patients with relapsed or refractory follicular lymphoma as a second...
OTTAWA, Ontario, Aug. 09, 2024 (GLOBE NEWSWIRE) — PsyCan, the not-for-profit trade association for the legal Canadian psychedelic medicine,...